These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 27497059

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nanostructured lipid carriers for the topical delivery of tretinoin.
    Ghate VM, Lewis SA, Prabhu P, Dubey A, Patel N.
    Eur J Pharm Biopharm; 2016 Nov; 108():253-261. PubMed ID: 27519827
    [Abstract] [Full Text] [Related]

  • 5. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
    Eskandani M, Nazemiyeh H.
    Eur J Pharm Sci; 2014 Aug 01; 59():49-57. PubMed ID: 24768857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anti-leishmanial activity of a topical miltefosine gel in experimental models of New World cutaneous leishmaniasis.
    Neira LF, Mantilla JC, Escobar P.
    J Antimicrob Chemother; 2019 Jun 01; 74(6):1634-1641. PubMed ID: 30815688
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.
    Dar MJ, Khalid S, McElroy CA, Satoskar AR, Khan GM.
    Int J Pharm; 2020 Jan 05; 573():118900. PubMed ID: 31765786
    [Abstract] [Full Text] [Related]

  • 11. Enhanced acute anti-inflammatory effects of CORM-2-loaded nanoparticles via sustained carbon monoxide delivery.
    Qureshi OS, Zeb A, Akram M, Kim MS, Kang JH, Kim HS, Majid A, Han I, Chang SY, Bae ON, Kim JK.
    Eur J Pharm Biopharm; 2016 Nov 05; 108():187-195. PubMed ID: 27634645
    [Abstract] [Full Text] [Related]

  • 12. Development of antileishmanial lipid nanocomplexes.
    Pham TT, Gueutin C, Cheron M, Abreu S, Chaminade P, Loiseau PM, Barratt G.
    Biochimie; 2014 Dec 05; 107 Pt A():143-53. PubMed ID: 24952352
    [Abstract] [Full Text] [Related]

  • 13. CpG oligodeoxynucleotide augments the antileishmanial activity of miltefosine against experimental visceral leishmaniasis.
    Sane SA, Shakya N, Haq W, Gupta S.
    J Antimicrob Chemother; 2010 Jul 05; 65(7):1448-54. PubMed ID: 20495208
    [Abstract] [Full Text] [Related]

  • 14. Platelet-activating factor receptor contributes to antileishmanial function of miltefosine.
    Gangalum PR, de Castro W, Vieira LQ, Dey R, Rivas L, Singh S, Majumdar S, Saha B.
    J Immunol; 2015 Jun 15; 194(12):5961-7. PubMed ID: 25980013
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of miltefosine treatment in Leishmania amazonensis-infected BALB/c mice.
    Godinho JL, Simas-Rodrigues C, Silva R, Ürmenyi TP, de Souza W, Rodrigues JC.
    Int J Antimicrob Agents; 2012 Apr 15; 39(4):326-31. PubMed ID: 22226653
    [Abstract] [Full Text] [Related]

  • 16. Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
    Soares S, Fonte P, Costa A, Andrade J, Seabra V, Ferreira D, Reis S, Sarmento B.
    Int J Pharm; 2013 Nov 18; 456(2):370-81. PubMed ID: 24036086
    [Abstract] [Full Text] [Related]

  • 17. Annealing as a tool for the optimization of lyophilization and ensuring of the stability of protein-loaded PLGA nanoparticles.
    Fonte P, Lino PR, Seabra V, Almeida AJ, Reis S, Sarmento B.
    Int J Pharm; 2016 Apr 30; 503(1-2):163-73. PubMed ID: 26972381
    [Abstract] [Full Text] [Related]

  • 18. Development, in vitro and in vivo evaluation of miltefosine loaded nanostructured lipid carriers for the treatment of Cutaneous Leishmaniasis.
    Khan AS, Ud Din F, Ali Z, Bibi M, Zahid F, Zeb A, Mujeeb-Ur-Rehman, Khan GM.
    Int J Pharm; 2021 Jan 25; 593():120109. PubMed ID: 33253802
    [Abstract] [Full Text] [Related]

  • 19. Investigation of Hexadecylphosphocholine (miltefosine) usage in Pegylated liposomal doxorubicin as a synergistic ingredient: In vitro and in vivo evaluation in mice bearing C26 colon carcinoma and B16F0 melanoma.
    Teymouri M, Farzaneh H, Badiee A, Golmohammadzadeh S, Sadri K, Jaafari MR.
    Eur J Pharm Sci; 2015 Dec 01; 80():66-73. PubMed ID: 26299343
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of tamoxifen and miltefosine combined therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis.
    Trinconi CT, Reimão JQ, Coelho AC, Uliana SR.
    J Antimicrob Chemother; 2016 May 01; 71(5):1314-22. PubMed ID: 26851606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.